Literature DB >> 36262865

Effectiveness of peripheral defocus spectacle lenses in myopia control: a Meta-analysis and systematic review.

Ji-Xian Ma1, Si-Wen Tian1, Qiu-Ping Liu1.   

Abstract

AIM: To evaluate the effectiveness of peripheral defocus spectacle lenses (PDLs) in myopia control.
METHODS: Literature retrieval on PubMed, Cochrane Library, Embase, and Web of Science databases, and the search time limit was from the establishment of each database to December 29, 2021 were conducted. Change of spherical equivalent refraction (SER) and axial change (AL) were extracted from the literatures that met the inclusion criteria, and RevMan5.3 software was used for Meta-analysis.
RESULTS: A total of 4 randomized controlled trials (RCTs) were included in this Meta-analysis, involving 770 myopic children. The results showed that PDLs could delay the progression of myopia in children with myopia compared with single vision spectacle lenses (SVLs; WMD=0.21 D, 95%CI: 0.01, 0.41, P=0.04). However, there was no significant difference in controlling the growth of axial length (AL) in myopic children (WMD=-0.10 mm, 95%CI: -0.21, 0.01, P=0.07). The results of the effectiveness of myopia control between the two spectacle lenses showed that PDLs were more effective in controlling the progression of myopia (OR=5.73, 95%CI: 2.58, 12.70, P<0.001) and delaying the growth of AL (OR=44.25, 95%CI: 8.84, 221.58, P<0.001) than SVLs, and the differences were statistically significant.
CONCLUSION: PDLs can control the progression of myopia compared with SVLs, but cannot delay the growth of AL, and the effectiveness of PDLs in myopia control better than SVLs. International Journal of Ophthalmology Press.

Entities:  

Keywords:  Meta-analysis; hyperopia defocus; myopia control; myopia defocus; peripheral defocus spectacle lenses

Year:  2022        PMID: 36262865      PMCID: PMC9522561          DOI: 10.18240/ijo.2022.10.20

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.645


  33 in total

Review 1.  Stopping the rise of myopia in Asia.

Authors:  Lothar Spillmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-23       Impact factor: 3.117

2.  Functional integration of eye tissues and refractive eye development: Mechanisms and pathways.

Authors:  Jody A Summers; Frank Schaeffel; Susana Marcos; Hao Wu; Andrei V Tkatchenko
Journal:  Exp Eye Res       Date:  2021-07-03       Impact factor: 3.467

3.  Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia: one-year results.

Authors:  Padmaja Sankaridurg; Brien Holden; Earl Smith; Thomas Naduvilath; Xiang Chen; Percy Lazon de la Jara; Aldo Martinez; Judy Kwan; Arthur Ho; Kevin Frick; Jian Ge
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

Review 4.  The Role of Orthokeratology in Myopia Control: A Review.

Authors:  Michael J Lipson; Moya M Brooks; Bruce H Koffler
Journal:  Eye Contact Lens       Date:  2018-07       Impact factor: 2.018

Review 5.  Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050.

Authors:  Brien A Holden; Timothy R Fricke; David A Wilson; Monica Jong; Kovin S Naidoo; Padmaja Sankaridurg; Tien Y Wong; Thomas J Naduvilath; Serge Resnikoff
Journal:  Ophthalmology       Date:  2016-02-11       Impact factor: 12.079

6.  Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis.

Authors:  Suzhen Wang; Jie Wang; Ningli Wang
Journal:  Ophthalmic Res       Date:  2020-08-11       Impact factor: 2.892

Review 7.  Update in pediatric myopia treatment strategies.

Authors:  Silvia Țone; Irina Andreea Niagu; Ștefan Tudor Bogdănici; Camelia Margareta Bogdănici
Journal:  Rom J Ophthalmol       Date:  2020 Jul-Sep

8.  IMI Impact of Myopia.

Authors:  Padmaja Sankaridurg; Nina Tahhan; Himal Kandel; Thomas Naduvilath; Haidong Zou; Kevin D Frick; Srinivas Marmamula; David S Friedman; Ecosse Lamoureux; Jill Keeffe; Jeffrey J Walline; Timothy R Fricke; Vilas Kovai; Serge Resnikoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-04-28       Impact factor: 4.799

9.  IMI Risk Factors for Myopia.

Authors:  Ian G Morgan; Pei-Chang Wu; Lisa A Ostrin; J Willem L Tideman; Jason C Yam; Weizhong Lan; Rigmor C Baraas; Xiangui He; Padmaja Sankaridurg; Seang-Mei Saw; Amanda N French; Kathryn A Rose; Jeremy A Guggenheim
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-04-28       Impact factor: 4.799

Review 10.  A Review of Current Concepts of the Etiology and Treatment of Myopia.

Authors:  Jeffrey Cooper; Andrei V Tkatchenko
Journal:  Eye Contact Lens       Date:  2018-07       Impact factor: 2.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.